Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2012
Cash flows from operating activities:      
Net income (loss) $ 5,367 $ (44,038) $ 41,982
Reconciliation of net income to net cash provided by (used in) operating activities:      
Depreciation and amortization 5,530 1,381 2,053
Goodwill impairment    2,884  
Stock-based compensation 1,871 1,407 1,205
Exchange rate loss 33 0 17
Gain on CNS asset sale      (64,502)
Cash proceeds from CNS Asset Sale     31,654
Gain on sale of ConferencePlus, net of tax      (20,489)
Loss (gain) on sale or disposal of fixed assets 8 (8) 18
Gain on sale of non-operating asset      (325)
Restructuring 335 149 1,217
Deferred taxes (9,312) 29,865 12,438
Changes in assets and liabilities:      
Accounts receivable (2,139) (979) 12,396
Inventories 457 (2,002) 1,852
Prepaid expenses and other current assets 742 (233) 1,002
Other assets 190 (240) (265)
Deferred revenue (404) (128) 336
Accounts payable and accrued expenses (3,223) 23 (23,820)
Accrued compensation 2,142 (206) (2,919)
Net cash provided by (used in) operating activities 1,597 (12,125) (4,956)
Cash flows from investing activities:      
Maturities of held-to maturity short-term debt securities 28,514 16,817 8,352
Maturities of other short-term investments 3,682 6,796 1,370
Purchases of held-to maturity short-term debt securities (21,955) (29,090) (16,746)
Purchases of other short-term investments (1,476) (4,417) (6,941)
Purchases of property and equipment (443) (379) (819)
Proceeds from sale of assets    15 325
cash proceeds sale of subsidiary      40,331
Proceeds from CNS asset sale      36,729
Acquisitions, net of cash acquired (66,170) (2,524)  
Changes in restricted cash 2,500 4,951 (7,451)
Net cash provided by (used in) investing activities (55,348) (7,831) 55,150
Cash flows from financing activities:      
Purchase of treasury stock (359) (12,733) (17,385)
Excess tax benefits from stock-based compensation      145
Proceeds from stock options exercised 1,677 87 1,684
Repurchase of subsidiary stock options      (117)
Net cash provided by (used in) financing activities 1,318 (12,646) (15,673)
(Gain) loss of exchange rate changes on cash (7) 3 (97)
Net increase (decrease) in cash and cash equivalents (52,440) (32,599) 34,424
Cash and cash equivalents, beginning of period 88,233 120,832 86,408
Cash and cash equivalents, end of period 35,793 88,233 120,832
Supplemental Cash Flow Information      
Cash paid (refunded) for income taxes, net $ 965 $ (524) $ 2,901